Question Everything. See who's reporting it.

RPG Life Sciences acquires Actis and Raghava for ₹215 crore to boost API business

Source: Business Standard

The story in brief

RPG Life Sciences acquired Actis Generics for ₹80 crore and Raghava Life Sciences for ₹135 crore, boosting its manufacturing capacity to 505 KL, product portfolio to 45, and customer base to over 250. The company plans to expand through new customers, geographic growth, and integration, while remaining debt-free.

NEWXFree on Android and iPhone. Open in NEWX